Pharmaceuticals in United States

May 2020 | 47 pages | ID: P4F64212451EN
MarketLine

Abstracts

Pharmaceuticals in United States

SUMMARY

Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
• The US pharmaceuticals market had total revenues of $409,400.0m in 2019, representing a compound annual growth rate (CAGR) of 3.4% between 2015 and 2019.
• On a cost basis, the American Healthcare system is the worst in the world, with numerous studies citing drug pricing in the US to be substantially higher than in any other high income country.
• The US population is aging, which is driving demand for pharmaceutical products, due to an increase in age-associated disease, such as diabetes and cardiovascular diseases.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in the United States
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States
• Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts

REASONS TO BUY

• What was the size of the United States pharmaceuticals market by value in 2019?
• What will be the size of the United States pharmaceuticals market in 2024?
• What factors are affecting the strength of competition in the United States pharmaceuticals market?
• How has the market performed over the last five years?
• Who are the top competitiors in the United States's pharmaceuticals market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent M&A activity?
7.6. How does government regulation impact leading players?
7.7. What impact is COVID-19 having on the market?

8 COMPANY PROFILES

8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. AstraZeneca AB
8.4. Merck & Co., Inc.

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: United States pharmaceuticals market value: $ billion, 2015-19
Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: United States pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: United States pharmaceuticals market share: % share, by value, 2019
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: AstraZeneca AB: key facts
Table 14: AstraZeneca AB: Key Employees
Table 15: Merck & Co., Inc.: key facts
Table 16: Merck & Co., Inc.: Annual Financial Ratios
Table 17: Merck & Co., Inc.: Key Employees
Table 18: Merck & Co., Inc.: Key Employees Continued
Table 19: United States size of population (million), 2015-19
Table 20: United States gdp (constant 2005 prices, $ billion), 2015-19
Table 21: United States gdp (current prices, $ billion), 2015-19
Table 22: United States inflation, 2015-19
Table 23: United States consumer price index (absolute), 2015-19
Table 24: United States exchange rate, 2015-19

List Of Figures

LIST OF FIGURES

Figure 1: United States pharmaceuticals market value: $ billion, 2015-19
Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: United States pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in the United States, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in the United States, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in the United States, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2019
Figure 10: United States pharmaceuticals market share: % share, by value, 2019